Table 2

Operative characteristics

No transfusion (n=289)Transfusion (n=323)P value*
Type of surgery, n (%)
 Hysterectomy170 (66%)§275 (85%)<0.001
 BSO198 (77%)¶282 (88%)0.001
 USO21 (8%)**16 (5%)0.11
 Omentectomy224 (87%)††300 (94%)0.005
 Pelvic lymphadenectomy47 (18%)‡‡85 (27%)0.019
 Para-aortic lymphadenectomy16 (6%)§§61 (19%)<0.001
 Bowel resection14 (5%)¶¶65 (20%)<0.001
 Splenectomy2 (1%)***30 (9%)<0.001
Country of treatment, n (%)<0.001
 Austria2 (1%)6 (2%)
 Belgium20 (7%)110 (34%)
 Canada49 (17%)22 (7%)
 Denmark10 (3%)3 (1%)
 France1 (0%)10 (3%)
 Ireland0 (0%)1 (0%)
 Italy20 (7%)9 (3%)
 Norway54 (19%)22 (7%)
 Portugal5 (2%)1 (0%)
 Spain28 (10%)29 (9%)
 Sweden12 (4%)11 (3%)
 The Netherlands33 (11%)62 (19%)
 United Kingdom55 (19%)37 (12%)
Operative time (min)†<0.001
 Mean±SD133±66245±118
 Median (range)120 (20–390)230 (10–720)
Transfusion of FFP, n (%)7 (2)105 (33)<0.001
Size of residual tumor (mm), n.(%)‡<0.001
 075 (29%)131 (42%)
 1–1067 (26%)82 (26%)
 ≥11114 (45%)96 (31%)

  • *χ2 and Fisher’s exact tests were used for categorical variables and Mann-Whitney test to compare medians between cohorts for continuous variables.

  • †Missing data for 53 no transfusion patients and 18 transfusion patients.

  • ‡Missing data for 33 no transfusion patients and 14 transfusion patients.

  • §Hysterectomy - 170/259 missing 30 (66%) 275/323 (85%) no missing

  • ¶BSO 198/258 (77%) missing 31. 282/322 (88%) missing 1

  • **USO 21/253 (8%) missing 36 16/319 (5%). missing 4

  • ††Omentectomy 224/259 (87%) missing 30. 300/321 (94%) missing 2

  • ‡‡Pelvic lymphadenectomy 47/257 (18%) missing 32. 85/319 (27%) missing 4

  • §§Para-aortic lymphadenectomy 16/258 (6%) missing 31 61/319 (19%) missing 4

  • ¶¶Bowel resection 14/259 (5%) missing 30 65/322 (20%) missing 1

  • ***Splenectomy 2/259 (1%) missing 30 30/322 (9%) missing 1

  • BSO, bilateral salpingo-oophorectomy; FFP, fresh frozen plasma; USO, unilateral salpingo-oophorectomy.